Order Article Reprints

Alexdottir MS, Bourgonje AR, Karsdal MA, Pehrsson M, Loveikyte R, van Dullemen HM, Visschedijk MC, Festen EAM, Weersma RK, Faber KN, et al. Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn’s Disease. International Journal of Molecular Sciences. 2022; 23(15):8137. https://doi.org/10.3390/ijms23158137

Alexdottir, Marta S., Arno R. Bourgonje, Morten A. Karsdal, Martin Pehrsson, Roberta Loveikyte, Hendrik M. van Dullemen, Marijn C. Visschedijk, Eleonora A. M. Festen, Rinse K. Weersma, Klaas Nico Faber, and et al. 2022. "Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn’s Disease" International Journal of Molecular Sciences 23, no. 15: 8137. https://doi.org/10.3390/ijms23158137

Alexdottir, M. S., Bourgonje, A. R., Karsdal, M. A., Pehrsson, M., Loveikyte, R., van Dullemen, H. M., Visschedijk, M. C., Festen, E. A. M., Weersma, R. K., Faber, K. N., Dijkstra, G., & Mortensen, J. H. (2022). Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn’s Disease. International Journal of Molecular Sciences, 23(15), 8137. https://doi.org/10.3390/ijms23158137